Study of the Prostatex Plus effectiveness in patients after transurethral resection for benign prostatic hyperplasia.

Introduction. The course of the postoperative period in patients with benign prostatic hyperplasia (BPH) who have undergone transurethral resection (TUR) remains an important issue. Adequate relaxation of the muscle tone of the prostatic urethra and bladder neck is crucial in the postoperative period. Materials and methods. The article presents the results of the study evaluating the drug Prostatex plus in patients with BPH who underwent transurethral resection of the prostate (TURP). Results. The results showed the most significant efficacy of Prostatex Plus when it was taken pre- and postoperatively (5 days before and 10 days after TURP) for patients with BPH if compared with the purely postoperative use of indomethacin and Prostatex Plus (10 days after TURP). The efficacy is confirmed by significantly improved urinary flow and the best pain relief in the postoperative period. Thus, the drug should be prescribed for the pre- and postoperative management of these patients. Conclusion. The use of Prostatex Plus can significantly improve the quality of life of patients in the postoperative period after TURP for BPH.